The immune system is a complex network of cells, tissues, organs and proteins that work together to support the health of the body. Having a strong, resilient defense system not only helps you maintain good physical health, it also supports your overall well-being, impacting your quality of life.
In 2009, the medical community was skeptical about the possibility of a bacterial strain that could activate the immune system. A scientific journal was published showing that different bacterial strains failed to show any effect in strenghtening the immune system.
Undeterred by skepticism, Kirin Kyowa Hakko Bio, a multi-billion-dollar Japanese biotech company in Japan pushed forward in their unwavering belief in the potential of beneficial bacteria to enhance immunity.
Their persistence paid off in 2010 when they successfully discovered LC-Plasma, a POST BIOTIC Compound created from the process of fermentation.
Unlike other companies eager to rush their products to market, KIRIN KYOWA HAKO-BIO prioritized safety and efficacy, choosing to invest heavily in extensive clinical research.
Over a period of ten years, they conducted 30 clinical studies, including 15 human trials, of which 13 demonstrated functional efficacy.
This dedication to scientific validation cemented the credibility of LC-PLASMA, now carrying the brand name: IMMUSE, as a powerful, clinically backed immune booster.
The studies done with LC-PLasma showed that it can ACTIVATE THE LEADER OF OUR IMMUNE SYSTEM called the pDC’s or plasmacytoid dentritic cells. When pDC’s are activated our entire immunity cells including NK Cells, T-Cells, B-Cells, Killer T-Cells function at optimum levels. Effectively killing harmful bacteria, infections and viruses.
Numerous studies have confirmed the antiviral and immune-enhancing effects of IMMUSE. Some of the most notable research findings include:
2022 (Japan): Clinical study on COVID-19 demonstrating its immune-boosting properties.
2024: Research on Dengue, Chikungunya, and Zika viruses showing promising antiviral effects.
2021: Study revealing its positive impact on Herpes 6 and Herpes 7.
2023: Clinical trials proving its effectiveness in reducing symptoms of Allergic Rhinitis.
Now, Filipinos can experience the benefits of this revolutionary discovery through IMMUKING, which harnesses the power of IMMUSE to provide unparalleled immune support.
FDA-approved and scientifically validated, IMMUKING stands as a powerful shield against viral threats and immune challenges.
With IMMUKING, you are not just taking a supplement—
you are empowering your body with the most advanced immune defense available today.
Experience the future of immunity, backed by science and trusted by experts worldwide.
Stronger immunity, stronger life—choose IMMUKING!